DGX
QUEST DIAGNOSTICS INC
QUEST DIAGNOSTICS INC (DGX) has 18 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 29, 2026.
Insiders have net sold $3.9M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:James E. Davis
- Employees:55,000
- HQ:Secaucus, NJ, US
- IPO:1996-12-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.9M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$26.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
DELANEY MARK EFirst filing | SVP & Chief Commercial Officer | Sale | 1,600 | $376K | Jul 29 | SEC ↗ |
KUPPUSAMY KARTHIKFirst filing | SVP, Clinical Solutions | Sale | 8,147 | $1.6M | Jun 8 | SEC ↗ |
Davis J. E.First filing | CEO and President | Sale | 10,000 | $1.9M | Jun 2 | SEC ↗ |
Congress trading DGX
See timeline →- RSen. Alan ArmstrongPurchase$1,001 - $15,0002026-03-27
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
QUEST DIAGNOSTICS INC is in the Healthcare sector.